Worldwide leader in #GeneEditing/#CRISPR. The first gene editing research institute based in a community cancer center, @ChristianaCare. Partners: @TheWistar.
We don’t know the future of this platform for news & knowledge sharing. Just in case, here’s where else you can connect with us:
Facebook: https://t.co/EhzmCwtUVo
Instagram: https://t.co/Fd3YiYbrNR
LinkedIn: https://t.co/z7D7ODSEIs
#TwitterDown#TwitterShutdown
Our research shows we can use gene editing to make lung cancer tumors more sensitive to chemo. Learn more about our breakthrough research and how it could one day help people fight #lungcancer: https://t.co/gjHoGTxqOw
We've been featured in our parent organization's 2024 annual report, highlighting the importance of gene editing research to the continued advancement of disease treatment. Read more here: https://t.co/vEtZ3L096X
We're thrilled to be among the Top 16 in the "Coolest Thing Made in Delaware" contest! Huge thanks to everyone who voted so far!
Head to https://t.co/ZDy9tUtjBX and cast your vote for CRISPR in a Box!
#CoolestThingDE
Although a federal judge has blocked the Trump administration’s cap on critical funding for medical and scientific research, higher education officials in Delaware are still concerned it could have serious ramifications on innovation in the First State.
https://t.co/dPWJeimkEf
How do we shape the future? One student at a time. Listen to the newest episode of 'For the Love of Health' to hear how we bring students into an immersive CRISPR experience!
https://t.co/D4wiLpYgvR
We're proud to see London McGill, one of our staff scientists, recognized for her presentation at the @AACR. McGill presented research on an approach for using CRISPR as a therapy for the treatment of pancreatic cancer.
https://t.co/Nj8gvgbxK3
It's tomorrow! Join us at Advanced Therapies in Philadelphia to get an insightful glimpse of the field as a whole - from CarT to cell barriers to CRISPR therapeutics! We're presenting and exhibiting, and we hope to see you there!
https://t.co/0XCeNMRm3s
As a nonprofit organization, we rely on philanthropy and donations to continue bringing genomic science to the forefront of medical research while we inspire the next generation of scientists. Interested in supporting us? Visit https://t.co/b92njsebTG . Every dollar helps!
Nothing's scary about CRISPR, but there's something spooky about our scientists today! We're enjoying the holiday by dressing up. To all the trick-or-treaters and celebrators of the day: go 'bananas' tonight, but don't go too crazy on the candy - maybe just a 'bite'!
Our scientific director Eric Kmiec is speaking at Advanced Therapies USA 2024 between November 12-13!
Be sure to join his session at America’s leading cell and gene event. Click below now to sign up as his guest!
#ADTherapiesUSA
https://t.co/Dvmsnts9bD
.@DelawareBio elected two new members to its board of directors: Natalia Rivera-Torres of @GeneEditingDE and Bruce Sachais of the Blood Bank of Delmarva and New York Blood Center Enterprises. https://t.co/BoLS4q67N1
Our scientific director Eric Kmiec is speaking at Advanced Therapies USA 2024 between November 12-13!
Be sure to join his session at America’s leading cell and gene event. Click below now to sign up as his guest!
#ADTherapiesUSA
https://t.co/Dvmsnts9bD
𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐞𝐰 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐲 𝐭𝐨 𝐄𝐧𝐡𝐚𝐧𝐜𝐞 𝐂𝐑𝐈𝐒𝐏𝐑–𝐂𝐚𝐬9-𝐌𝐞𝐝𝐢𝐚𝐭𝐞𝐝 𝐇𝐨𝐦𝐨𝐥𝐨𝐠𝐨𝐮𝐬 𝐑𝐞𝐜𝐨𝐦𝐛𝐢𝐧𝐚𝐭𝐢𝐨𝐧
In a hunt for ways to improve the efficiency of CRISPR–Cas9-mediated homologous recombination, researchers at ETH Zürich and Memorial Sloan Kettering Cancer Center find that a single exonuclease, TREX1, reduces HDR efficiency when the repair template is a single-stranded or linearised double-stranded DNA. TREX1 knockout improved HDR efficiency, indicating new avenues for increasing CRISPR-Cas9-mediated HDR in TREX1-expressing contexts.
The study was led by Jacob Corn at ETH Zürich.
https://t.co/6AcGGnk1Fc
#crisprmedicinenews #crisprmedicine #crisprcas9 #fanconianemia #geneediting
Using CRISPR-Cas9 to knock out CD5, researchers have significantly improved the efficacy of adoptive T-cell therapies for both haematological and solid cancers. We're proud to highlight our fellow researchers in the mid-Atlantic region.
https://t.co/jSFA03uosB
In this study, the first example of heritable gene editing in the entire phylum of Tardigrada was researched, evaluated, and deemed a success. This foray into the world of 'water bears' could have major implications for human genome editing in the future.
https://t.co/0fAKhExYA2
Human cells repair RNA breaks induced by a programmable CRISPR system, paving the way for temporary treatments for genetic diseases.
https://t.co/KVPnK2w5wR
A team of scientists at Gladstone Institutes has developed a new method that enables them to make precise edits in multiple locations within a cell all at once, opening up the ability to map treatments for complex genetic diseases.
https://t.co/u5wm4G5y1J
A recent British study at the University of Bristol indicates that the last universal common ancestor (LUCA) possessed an early form of the CRISPR-Cas immune system, dating back approximately 4.2 billion years.
https://t.co/TMjhS78meJ